作者:Kuo Xu、Xin Xu、Fuhao Chu、Mina Wang、Penglong Wang、Guoliang Li、Jixiang Song、Yuzhong Zhang、Haimin Lei
DOI:10.1007/s11164-014-1737-z
日期:2015.9
The lead compound T-OA, 3β-hydroxyolean-12-en-28-oic acid-(3,5,6-trimethylpyrazine-2-yl) methyl ester, which exhibited promising anticancer effects in vitro and in vivo, has previously been reported. According to the structural features, a series of novel T-OA analogues were synthesized via amino condensation reaction. These analogues’ cytotoxic activities were evaluated on five cancer cell lines (Bel-7402, HepG-2, HT-29, Hela, BGC-823) and hepatic stellate cell line (HSC-6). Among the candidates, compounds 8 and 16 showed promising effects; 3β-hydroxy-lup-20(29)-ene-28-oic acid-(3,5,6-trimethylpyrazin-2-yl) methyl amine (16) even possessed superior bioactivities to positive drugs (cisplatin and ursolic acid), which was worthy of further study. In addition, structure–activity relationships and Clog P values of T-OA analogues were briefly discussed.
先导化合物T-OA,即3β-羟基烯-12-烯-28-酸-(3,5,6-三甲基吡嗪-2-基)甲酯,已被报道在体外和体内显示出良好的抗癌效果。根据结构特征,通过氨基缩合反应合成了一系列新的T-OA类类似物。这些类似物在五种癌细胞系(Bel-7402、HepG-2、HT-29、Hela、BGC-823)和肝星形细胞系(HSC-6)上评估了其细胞毒活性。在候选化合物中,化合物8和16显示出良好的效果;3β-羟基-露皮-20(29)-烯-28-酸-(3,5,6-三甲基吡嗪-2-基)甲胺(16)甚至具有优于阳性药物(顺铂和熊果酸)的生物活性,值得进一步研究。此外,简要讨论了T-OA类类似物的结构-活性关系和Clog P值。